CompletedNCT02579642
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 70 Years
- Countries
- Canada
- Sponsor
- University of Alberta
- Condition
- Depression
CompletedNCT03658824
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Exeter
- Condition
- Bipolarity
CompletedNCT04855409
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- Mehmet Diyaddin Güleken
- Condition
- Bipolarity
CompletedNCT03404882
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Alberta
- Condition
- Schizophrenia
CompletedNCT00282464
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00141271
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT00055575
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Depression
CompletedNCT03965871
This study exists to compare options and see whether the medication Inhaled offers something meaningfully different. Researchers are trying to understand whether the medication Inhaled can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Poland
- Sponsor
- Celon Pharma SA
- Condition
- Bipolarity
CompletedNCT01431573
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Depression
CompletedNCT00483548
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Australia, India, United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
WithdrawnNCT03764683
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
BipolarityOtherFrom 18 Years to 75 Years
- Countries
- Global
- Sponsor
- Massachusetts General Hospital
- Condition
- Bipolarity
CompletedNCT00454883
This study exists to see whether the medication Ziprasidone can make care clearer and more responsive. Researchers are trying to understand whether the medication Ziprasidone can give earlier or clearer feedback during care.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT00400088
This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Depression
TerminatedNCT02882711
This study exists to explore whether ketamine treatment could improve care and understanding. Researchers are trying to understand whether ketamine treatment can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Depression
CompletedNCT02918097
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- Federal University of Rio Grande do Sul
- Condition
- Bipolarity
CompletedNCT03062267
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia
CompletedNCT00436020
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 70 Years
- Countries
- Australia
- Sponsor
- Bayside Health
- Condition
- Bipolarity
CompletedNCT00961961
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Pennsylvania
- Condition
- Bipolarity
CompletedNCT03638687
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Depression
CompletedNCT01869374
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 55 Years to 90 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Depression
CompletedNCT04469322
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- San Diego Veterans Healthcare System
- Condition
- Depression
CompletedNCT02765100
This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making.
DepressionOtherFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
- Condition
- Depression
TerminatedNCT01624831
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- University of Arizona
- Condition
- Schizophrenia
CompletedNCT01570972
This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of Arizona
- Condition
- Schizophrenia
CompletedNCT01196286
This study exists to explore whether psychoeducation, a guided learning and support program, could improve care and understanding. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of Arizona
- Condition
- Schizophrenia